Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial

PABLO PEREZ MARTINEZFRANCISCO JAVIER DELGADO LISTARAUL MIGUEL LUQUE HUERTAS2026-01-292026-01-29202110.1016/j.trsl.2021.07.0012-s2.0-85112617705https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33795Biochemistry (medical)Physiology (medical)Public Health, Environmental and Occupational HealthBeta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trialresearch article